Receive the latest alerts via email

New Valuation: Incyte Corporation (INCY)

Incyte Corporation (NASDAQ:INCY) 
over-valued
 Par 12%

Website https://www.incyte.com
Sector Health Care
Industry Biotechnology
Fiscal Year End December
Market Cap $18B
Beta 0.73
Dividends per share $0.00
Current Price $78.24
Autochartist™ Valuation $69.00
Conclusion
over-valued
 Par -12%

Download PDF Report

Total
0
Shares
Previous Post

New Valuation: Lam Research Corp (LRCX)

Next Post

New Valuation: Amgen Inc (AMGN)

Related Posts